Rus Eng
Main / Company's news / V Russian symposium “Proteins and peptides” took place in Petrozavodsk

V Russian symposium “Proteins and peptides” took place in Petrozavodsk

22 August 2011

August 8-12, V Russian symposium “Proteins and peptides” took place in Petrozavodsk, the general sponsor of event became the pharmaceutical company GEROPHARM. The Russian leading scientists whose studies dedicated to mechanism of action of peptide, methods of its receipt and usage in pharmacology were invited to take a part in the symposium.

GEROPHARM pays great attention to research of peptide nature. Company’s specialists regularly participate in the specialized scientific events. The symposium in Petrozavodsk wasn’t an exception. GEROPHARM’s scientists together with scientists of Institute of Higher Nervous Activity and Neurophysiology of RAS, Pavlov Institute of Physiology of RAS, Moscow State University and State Research Institute of Pharmacology of Tomsk Scientific Center of RAMS were authors of several reports, dedicated to creation of new peptide medicinal drugs.

The report by V. Aniol presented the results of the joint research by group of scientists of Institute of Higher Nervous Activity and Neurophysiology of RAS and GEROPHARM under the direction of N. Gulyaeva has aroused a special interest. The subject of report was the study of antiepileptic action of Cortexin. A separated stand session for young scientists also was organized within the symposium.

Beginner researchers presented their own scientific developments of study of the biology mechanisms of action of peptide in an organism. The authors of the best works were regarded by GEROPHARM and charity foundation called “Young Hippocrates” with grants to continue the research projects.

Development of peptide preparations is one of the perspective directions of the medicine development. Peptide drugs are generally recognized for their mild action and absence of contraindications as well as low dosage. Therefore GEROPHARM annually invests money in the development of innovative peptide drugs for the treatment of social significant diseases.

You are a health care professional?

Go up